These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Proceedings: Pellagroid eruption and deep recurrent ataxia due to a tryptophan metabolism disorder]. Nuyts JP; Gaudier B; Caridroit M; Leclerc F Pediatrie; 1975; 30(5):539. PubMed ID: 1178284 [No Abstract] [Full Text] [Related]
3. BIOCHEMICAL ASPECTS OF THE HARTNUP DISEASE. I. RESULTS OF INTRAVENOUS AND ORAL TRYPTOPHAN LOADING TESTS IN A CASE OF HARTNUP DISEASE. DELAEY P; HOOFT C; TIMMERMANS J; SNOECK J Ann Paediatr; 1964; 202():145-60. PubMed ID: 14133234 [No Abstract] [Full Text] [Related]
5. [THE CLINICAL FORM OF HARTNUP'S DISEASE]. DEMEULEMEESTER F Acta Paediatr Belg; 1963; 17():215-22. PubMed ID: 14107571 [No Abstract] [Full Text] [Related]
6. Indole production in Hartnup disease. ASATOOR AM; CRASKE J; LONDON DR; MILNE MD Lancet; 1963 Jan; 1(7273):126-8. PubMed ID: 13965100 [No Abstract] [Full Text] [Related]
7. Hartnup disease in psychiatric practice: clinical and biochemical features of three cases. HERSOV LA; RODNIGHT R J Neurol Neurosurg Psychiatry; 1960 Feb; 23(1):40-5. PubMed ID: 14401403 [No Abstract] [Full Text] [Related]
8. BIOCHEMICAL ASPECTS OF THE HARTNUP DISEASE. II. SOME OBSERVATIONS ON RATS ABOUT TRYPTOPHAN METABOLISM. DELAEY P; HOOFT C; TIMMERMANS J; SNOECK J Ann Paediatr; 1964; 202():253-62. PubMed ID: 14135037 [No Abstract] [Full Text] [Related]
9. BIOCHEMICAL ASPECTS OF THE HARTNUP DISEASE. III. GENERAL DISCUSSION AND CONCLUSIONS. DELAEY P; HOOFT C; TIMMERMANS J; SNOECK J Ann Paediatr; 1964; 202():321-31. PubMed ID: 14168315 [No Abstract] [Full Text] [Related]
10. HARTNUP DISEASE IN TWO SIBLINGS. CLINICAL OBSERVATIONS AND BIOCHEMICAL STUDIES. VISAKORPI JK; HJELT L; LAHIKAINEN T; OHMAN S Ann Paediatr Fenn; 1964; 10():42-56. PubMed ID: 14116920 [No Abstract] [Full Text] [Related]
11. [Tryptophan metabolism in patients with pellagra]. Brune GG; Brune RM; Wiskemann A Arch Dermatol Forsch; 1970; 240(1):44-54. PubMed ID: 4252305 [No Abstract] [Full Text] [Related]
14. CLINICAL AND BIOCHEMICAL FEATURES OF A CASE OF HARTNUP DISEASE. SRIKANTIA SG; VENKATACHALAM PS; REDDY V Br Med J; 1964 Feb; 1(5378):282-5. PubMed ID: 14085009 [No Abstract] [Full Text] [Related]
15. [Clinical picture of Hartnup disease. Without urine amino acids or any other identified metabolic disorder (a new entity)]. Da Gloria ER; Assunção JG; Costa MA Med Cutan Ibero Lat Am; 1990; 18(4):227-31. PubMed ID: 2077308 [TBL] [Abstract][Full Text] [Related]
16. [Various current findings in the problem of pellagra]. Mainardi L; Bissanti A Acta Vitaminol Enzymol; 1968; 22(3):90-7. PubMed ID: 5756732 [No Abstract] [Full Text] [Related]
18. Biochemistry of tryptophan in health and disease. Bender DA Mol Aspects Med; 1983; 6(2):101-97. PubMed ID: 6371429 [No Abstract] [Full Text] [Related]
19. [Pathologic deviations of tryptophan metabolism and their biochemical examination]. Dreux C Ann Biol Clin (Paris); 1968; 26(1):57-72. PubMed ID: 4231425 [No Abstract] [Full Text] [Related]
20. Familial pellagra-like skin rash with neurological manifestations. Freundlich E; Statter M; Yatziv S Arch Dis Child; 1981 Feb; 56(2):146-8. PubMed ID: 6451201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]